Call
+918447748545

Published on: May 22, 2021
3 minute read
By: Dr Rajan Choudhary

COVID Associated Black Fungus: Succumbing To Black Fungus !

COVID associated Black Fungus: What you need to know

As COVID spreads across India, there has been an increase in reports of associated infection with a black fungus occurring in some patients. It affects the nose, mouth, eyes, and lungs, and can be fatal. This is an infection we need to be educated on, and early recognition of it can be life-saving. Today we will talk about Mucormycosis, the black fungus responsible for these infections, and what you should do to prevent or recognize an infection.

If you want to learn how to recognize the infection, go down to the INFECTION section of the article.

FUNGUS

When our body gets infected by a bacteria or virus, the signs and symptoms are often recognized early because bacteria and viruses are aggressive, with toxins and mechanisms designed to cause harm to our body and cause easily recognizable symptoms. Fungi on the other hand are slow-growing, and usually, our bodies can fight usually fight these infections before they become a problem. We breathe in fungal spores all the time, especially when outside, in the garden, or in fields, and they cause no harm.

Mucormycosis, the responsible fungus, is found in soil, and decaying fruits and vegetables. It can enter our body by inhalation, by eating foods infected with it, or by direct contact with an open wound, thereby entering our blood. It can be found inside the nose of healthy people, causing no problems or disease. Before the COVID pandemic, infection by mucormycosis was up to 80 times more prevalent in India than in other developed countries, though still rare.

IMMUNOSUPPRESSION

Looking at case reports of patients infected with mucormycosis shows a common theme. Immunocompromised patients are at much higher risk of infection by the fungus and are more likely to have severe disease. This includes patients with diabetes, poorly controlled diabetes, patients taking steroids, organ transplant patients (who are usually on immunosuppressive medications to prevent rejection), those with blood cancer (leukemia/lymphoma, reducing your blood immunity).

Diabetes (especially poorly controlled diabetes) is a major problem in these cases, as diabetes is fairly common in India, can lay unrecognized, and if not controlled or treated appropriately the rising blood sugar levels can damage your arteries, nerves, and significantly lower your immunity. Any infection in diabetic patients can be more difficult to treat and spread more quickly, and this is made worse by COVID-19.

COVID causes widespread inflammation throughout the body, especially the lungs, and the resulting damage causes difficulty breathing and death by respiratory failure. Steroids are currently our best way to treat COVID, by suppressing the body’s immune system and preventing lung damage. Unfortunately, this also allows mucormycosis spores inhaled by COVID patients to infect the now vulnerable, damaged airway, lungs, and sinuses, and start spreading. The body’s response to the infection is dampened by the steroids, and in those with diabetes, it is hindered further.

INFECTION

The black fungus usually spreads in the nose and sinuses of the skull, as it prefers a warm, humid environment. From here it can spread into the eyes and in rare cases the brain.

Recognize the symptoms of the fungus, and be very suspicious in patients with diabetes or those who have had high doses of steroids.

- Facial swelling on one side

- Nose or sinus congestion

- Pain in the sinuses, around the nose, and eyes

- Black mold growing around the nose or mouth

- Fever, headache

When it infects the lungs it can cause symptoms such as cough, shortness of breath, or chest pain. Unfortunately, this can be difficult to separate from symptoms of COVID infection.

If you suspect you or someone you know has these symptoms, and they have the risk factors of immunosuppression or diabetes, you should visit a doctor early. Mucormycosis has a high mortality rate, and a delay in diagnosis by even a week can double it. Your doctor will take swab samples from your nose and look for signs of the fungus under a microscope. Blood tests and scans are also helpful in identifying the fungal infection.

TREATMENT AND PREVENTION

Treatment of mucormycosis requires IV antifungals such as Amphotericin B and may involve surgery to remove the infected areas and prevent further spread. This can include surgery in and around the nose, sinuses, and in rare cases even the eyes. This all depends on the extent of the fungal infection.

Prevention is key in these cases. Simple measures such as wearing a mask to reduce inhalation of spores can minimize infection, especially in the vulnerable, though it may not prevent it if they already had spores present in their nose and sinuses. Glucose tests to look for diabetes, and strict control of diabetes will improve your chances significantly. Keeping your blood sugar levels within the normal range is very important, so if you are diabetic now is the time to stick to your diabetic diet and medications.

Finally, we need to be careful when using immunosuppressive medications to treat COVID, and determining which patients should receive steroids (dexamethasone, prednisolone) and other drugs such as tocilizumab. If you are young and healthy, or you have a milder infection of COVID-19, it may be better for you to not take steroids early. Those with more serious COVID-19 infections may need steroids to survive, and in these cases frequent checks for mucormycosis infection is advisable.

The rise in this rare fungal disease in patients with COVID-19 presents a problem, as we do not have much literature to base our recommendations on, the disease is slow-growing and can be difficult to treat. But as always, understanding the disease process for black fungus and knowing its symptoms is important, as is informing your family and friends about this disease.

Read Blog

Digital Pharmacy Platforms India: How SecondMedic Is Transforming Medicine Access Through Technology

India’s healthcare system is rapidly digitizing, and one of the most impactful innovations is the rise of digital pharmacy platforms. These platforms make it easier for people to order medicines online, manage prescriptions, and access healthcare services without visiting a physical store.

As chronic diseases, online consultations, and digital health records become more common, digital pharmacy solutions are now a vital part of India's healthcare infrastructure. SecondMedic plays a key role in this evolution by providing secure, fast, and integrated digital pharmacy services.

What Are Digital Pharmacy Platforms?

Digital pharmacy platforms are online systems that allow users to:

Order prescription medicines
Upload or sync digital prescriptions
Schedule refills
Purchase OTC products
Track orders
Access pharmacist support

Instead of visiting a traditional pharmacy, users can manage medication needs from anywhere in India.

Why Digital Pharmacies Matter in India

India sees high demand for medicines due to:

Rising chronic diseases
Aging population
Urban mobility challenges
Increasing telemedicine adoption
Growing digital health awareness

Digital pharmacies bridge the gap between medical consultation and medication access.

Key Benefits of Digital Pharmacy Platforms

1. Convenience and Accessibility

Patients can order medicines anytime, especially helpful for elderly individuals or those living in remote areas.

2. Time and Cost Savings

Digital ordering eliminates long queues, multiple store visits, and pricing uncertainties.

3. Verified, Authentic Medicines

Reputed platforms ensure drugs come from licensed pharmacies with full batch traceability.

4. E-Prescription Integration

Digital prescriptions reduce manual errors and support seamless ordering.

5. Chronic Disease Medication Management

Automated refill reminders and scheduled deliveries help maintain treatment consistency.

6. Privacy and Discretion

Useful for sensitive medication categories where users may prefer confidential ordering.

The Growing Digital Pharmacy Market in India

According to Statista 2025:

The Indian e-pharmacy market is expected to reach USD 10 billion by 2027.
Nearly 35 percent of urban households now use digital pharmacy services.
Chronic disease patients are the largest user segment.

Government initiatives like ABDM also promote secure and standardized digital prescriptions.

SecondMedic’s Digital Pharmacy Ecosystem

SecondMedic integrates pharmacy services seamlessly within its broader digital health platform.

1. Online Medicine Ordering

Users can order medicines directly through the SecondMedic app or website.

2. E-Prescription Sync

Prescriptions from SecondMedic doctors sync automatically, reducing errors and delays.

3. Verified Inventory

All medicines are sourced from certified pharmacies with temperature-controlled storage and valid expiry cycles.

4. Chronic Care Refill System

For diabetes, hypertension, thyroid disorders, and cardiac conditions, patients can schedule monthly refills.

5. Real-Time Tracking

Users get live updates on order status, dispatch, and delivery.

6. Secure Payment Gateway

Digital payments are supported through encrypted channels, ensuring safety and transparency.

7. Integration with Medical Consultations

After virtual consultations, prescribed medicines can be ordered instantly on the same platform.

How Digital Pharmacy Platforms Support Telemedicine

Telemedicine has become a cornerstone of modern healthcare. Digital pharmacies complement this by:

Enabling immediate access to prescribed medicines
Ensuring continuity of care
Reducing patient dependency on physical pharmacies
Streamlining doctor-to-pharmacy communication

Together, they create an efficient, patient-centered care loop.

Challenges in India’s Pharmacy System and How Digital Platforms Solve Them

1. Fragmented Pharmaceutical Distribution

Digital systems bring transparency and accountability.

2. Prescription Mismanagement

E-prescriptions minimize errors and duplication.

3. Limited Accessibility in Rural Areas

Digital ordering delivers medicines directly to underserved regions.

4. Inconsistent Medicine Availability

Real-time inventory ensures availability and alternatives.

5. Lack of Patient Awareness

Digital platforms offer information on dosage, interactions, and side effects.

Regulatory Framework for Digital Pharmacies in India

To ensure safety and compliance, digital pharmacies follow:

Drugs and Cosmetics Act (1940)
Pharmacy Practice Regulations
ABDM standards for digital prescriptions
DPDP Act for data security
CDSCO guidelines for online pharmacies

SecondMedic maintains full compliance with regulatory requirements.

Future of Digital Pharmacy in India

The sector is expected to grow due to:

AI-based medicine recommendations
Smart refill systems
Blockchain for supply chain verification
Automated pharmacy logistics
Drone-based delivery pilots in some states

SecondMedic is actively building tools to support next-generation pharmacy automation and integrated digital care.

Why Patients Trust SecondMedic’s Pharmacy System

Authentic and verified medicines
Transparent pricing and secure payments
Direct connection with healthcare consultations
Support for chronic care medication
Nationwide delivery capability
User-friendly ordering process
Compliance with all digital health safety standards

SecondMedic brings reliability, convenience, and safety under one unified digital healthcare platform.

Conclusion

Digital pharmacy platforms are redefining how India accesses medicines. They improve convenience, enhance safety, support telemedicine, and empower patients to manage chronic conditions more effectively. SecondMedic’s digital pharmacy provides an integrated solution that combines e-prescriptions, secure ordering, and nationwide delivery to simplify healthcare access.

To order medicines or explore digital pharmacy services, visit www.secondmedic.com

References

Statista – India E-Pharmacy Market Outlook 2025
IMARC Group – Digital Healthcare Market India 2025
NITI Aayog – Digital Health Tech Landscape 2024
ABDM – Digital Prescription Guidelines
FICCI – Healthcare Innovation Report 2024

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.